© 2018 by ICD Pharma. 

​Clinical Articles

High Dose CBD

 

Schizophrenia

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Read More

Opiate addiction withdrawal syndrome

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Read More

Epilepsy

Cannabidiol in patients with treatment-resistant epilepsy:

an open-label interventional trial

Read More 

Alzheimer’s Disease

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease

Read More

Parkinson’s Disease

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

Read More